Vygon, a group specializing in single-use medical devices, and Oncomfort, the Belgian inventor of Digital Sedation – a method for relieving patients’ pain and anxiety without medication – has announced a commercial partnership in six European countries.
The synergy between Vygon’s specialisation and Oncomfort’s fields of application aims to enable greater acceleration of the adoption of Digital Sedation by healthcare professionals and patients.
Digital Sedation is a CE marked medical device designed to relieve, without medication, the pain and anxiety of patients, combining hypnotherapy and integrative therapeutic techniques through virtual reality glasses.
Mario Huyghe, CEO at Oncomfort, said: “We are delighted to be partnering with Vygon. It has an international presence in specialties where Oncomfort’s efficacy has been proven. Our method covers light to deep sedation, allowing it to be used in the different clinical areas in which Vygon is active. Our hypnotherapeutic sessions using virtual reality have been designed for internationalisation, with sessions already available in 12 languages. Together with Vygon, we will deploy configurations targeted for each clinical activity. This will enable us to provide a personalised approach to patients and healthcare professionals across all hospitals and clinics.”
Through this partnership, Vygon will offer healthcare professionals a new therapeutic option in performing their interventions – with less medication, aiming to provide less disruption, more comfort for the patient, without the usual side effects associated with pharmacological therapies. This partnership is effective immediately; the Sedakit device will be introduced to the market in January 2021 in France, the UK, Ireland, Spain, Portugal and Italy.
Vygon specialises in the development and commercialisation of medical devices that are used by healthcare professionals in multiple clinical areas, in particular intravascular therapies, anaesthesia and emergency care, as well as cardiology and vascular surgery. Oncomfort has created its digital therapy to reduce pain and anxiety for patients in these clinical areas.
Stéphane Regnault, president of Vygon, said: “Vygon has long-standing experience in combined therapeutic approaches. Oncomfort’s innovative technique is in line with our expansion in this field. Our international presence in hospitals and clinics allows us to integrate Oncomfort’s solution into interventional approaches to ensure that the patient can benefit from the best care.”
